| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.19B | 3.00B | 2.46B | 2.28B | 1.95B | 1.76B |
| Gross Profit | 810.60M | 2.69B | 2.19B | 828.60M | 693.90M | 561.70M |
| EBITDA | 678.20M | 675.00M | 641.40M | 591.30M | 439.10M | 415.40M |
| Net Income | 271.10M | 256.20M | 12.90M | 291.20M | 190.50M | 169.60M |
Balance Sheet | ||||||
| Total Assets | 4.11B | 4.06B | 3.70B | 3.33B | 2.84B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 211.20M | 268.00M | 299.90M | 179.60M | 122.80M | 168.60M |
| Total Debt | 1.76B | 2.09B | 1.87B | 1.45B | 1.24B | 967.70M |
| Total Liabilities | 2.43B | 2.77B | 2.50B | 1.95B | 1.71B | 1.40B |
| Stockholders Equity | 1.68B | 1.28B | 1.18B | 1.37B | 1.12B | 1.07B |
Cash Flow | ||||||
| Free Cash Flow | 194.00M | 244.60M | 198.40M | 293.80M | 167.90M | 184.70M |
| Operating Cash Flow | 441.80M | 409.60M | 350.10M | 439.90M | 286.80M | 265.80M |
| Investing Cash Flow | -253.50M | -327.70M | -226.80M | -267.00M | -405.90M | -120.50M |
| Financing Cash Flow | -251.40M | -120.00M | -3.10M | -121.20M | 77.40M | -379.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$4.85B | 19.69 | 42.87% | 3.64% | 1.48% | 25.46% | |
66 Neutral | AU$11.23B | 40.15 | 18.38% | 1.77% | 18.18% | 4272.22% | |
65 Neutral | AU$2.64B | 31.06 | 17.57% | 2.74% | 7.20% | 32.60% | |
64 Neutral | AU$5.27B | 38.96 | 6.66% | 3.14% | -4.53% | 97.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | AU$2.33B | 83.66 | 4.71% | 3.25% | 12.18% | -73.81% | |
56 Neutral | AU$1.77B | 23.40 | 9.26% | 1.54% | 15.14% | -7.23% |
ALS Limited announced a change in the interest of its director, Malcolm Deane, who disposed of 7,356 ordinary shares through an on-market trade to meet taxation obligations. This transaction reduced Deane’s holding to 63,376 ordinary shares, while his performance and service rights remained unchanged. The disposal of shares is a routine adjustment for tax purposes and does not indicate any strategic shift or operational change within the company.
ALS Limited has released its H1 FY26 financial results for the six months ending September 30, 2025. The company has announced a reclassification of specific amounts in its financial reporting to provide a clearer representation of its core operating performance, starting in H2 FY26. This change aims to simplify the understanding of its financial results and enhance transparency for stakeholders.
ALS reported a strong financial performance for the first half of the fiscal year 2026, with a 14.7% increase in underlying EBIT and a 13.3% rise in revenue, driven by robust growth in the commodities sector. The company maintained resilient margins despite price discounting in previous quarters and achieved significant organic growth in its minerals and life sciences segments. ALS’s strategic capital deployment and balance sheet strength position it well for continued growth, with a declared interim dividend reflecting confidence in its financial health.
ALS Limited has announced a dividend distribution of AUD 0.194 per share for its ordinary fully paid shares, covering the six-month period ending September 30, 2025. The dividend will be paid on December 17, 2025, with an ex-date of November 26, 2025, and a record date of November 27, 2025, reflecting the company’s ongoing commitment to returning value to shareholders.
ALS Limited has released its condensed interim financial report for the half year ending 30 September 2025. The report provides a comprehensive overview of the company’s financial performance, including profit and loss, balance sheet, and cash flow statements. This release is crucial for stakeholders as it offers insights into the company’s operational efficiency and financial health during the period.
ALS Limited addressed a query from the ASX regarding the late lodgement of performance rights granted to Mr. Malcolm Deane. The company attributed the delay to human error within its Corporate Governance team and confirmed that necessary compliance procedures are in place. ALS has reviewed and enhanced its processes, embedding key regulatory obligations into new software and providing training to ensure future compliance. The company emphasizes its commitment to regulatory adherence and does not see the need for additional steps beyond enforcing existing protocols.
ALS Limited announced a change in the director’s interest, with Malcolm Deane acquiring 146,884 Performance Rights under the company’s 2025 Long-Term Incentive Plan, following shareholder approval at the 2025 AGM. This acquisition increases Deane’s total holdings and reflects ALS’s commitment to aligning executive interests with company performance, potentially impacting stakeholder confidence and the company’s market positioning.
ALS Limited has announced the issuance of unquoted equity securities, specifically performance rights and service rights, as part of an employee incentive scheme. This move reflects ALS Limited’s ongoing commitment to employee engagement and retention, potentially enhancing its operational efficiency and market competitiveness.
ALS Limited has announced the issuance and conversion of unquoted equity securities, specifically ordinary fully paid shares, totaling 552,093 shares. This move reflects the company’s ongoing efforts to manage its capital structure and may impact its market positioning by potentially increasing liquidity and shareholder value.